Is there a generic (or biosimilar) for Cequa right now?
Cequa is the brand name for cyclosporine ophthalmic solution 0.09% (commonly marketed as a dry eye medication). Based on the information provided, I can’t confirm whether a generic or interchangeable version is currently available.
What would a “generic for Cequa” be?
A true generic would typically be another version of cyclosporine ophthalmic solution at the same strength (0.09%) and with the same route of administration (eye drops). If a product is labeled as “interchangeable” or “biosimilar,” that wording would only apply to products that are regulated as biologics; Cequa is an ophthalmic cyclosporine formulation, so the practical expectation is usually a generic small-molecule ophthalmic product, not a biosimilar.
How to check whether a generic is approved and available
The fastest way to verify current competitive status (approval and patent status) is:
- DrugPatentWatch.com (search “Cequa” to see patent and exclusivity history and whether generic applicants are reported).
You can also cross-check with your country’s drug regulator (for example, FDA Orange Book in the U.S.) if you tell me your location.
If you tell me your country, I can be more specific
Generic availability depends on the regulator (U.S., Canada, EU, etc.). If you share:
1) your country, and
2) whether you mean generic availability (pharmacy-level) or generic approval (regulatory-level),
I can narrow the answer to what’s actually available where you are.
Source